Dedicated to keeping Alaska free from Capital Punishment.
There are many easy and convenient ways to contact AADP. If you are interested in supporting AADP by purchasing merchandise or making a donation please click here.
For all other inquiries feel free to fill out the following contact form or use the contact information below.
The National Coalition to Abolish the Death Penalty applauds Governor O’Malley and the Maryland General Assembly for introducing and considering Senate Bill 276 and House Bill 295: Death Penalty Repeal and Appropriation from Savings to Aid Survivors of Homicide Victims and urges its passage...
Read Governor O’Malley’s testimony
View NCADP's Website for the full article
At a recent event at Willamette University in Oregon, various state leaders in the fields of law and criminal justice spoke critically about the state's death penalty. Former Supreme Court Chief Justice Paul De Muniz (pictured) said the death penalty was "bad public policy," almost never resulting in an execution. He spoke of having defended a murderer sentenced to death in 1988. Twenty-five years later, the Justice noted, he is now retired after a full career in the law, while the inmate is still in the midst of his appeals on death row. Noting the $28 million spent annually on the death penalty, Justice De Muniz said, “The death penalty is getting a ‘pass’ from legislative scrutiny, when looking for ways to trim Oregon’s budget to fund starving schools and public safety.” The former Superintendent of the State Penitentiary, Frank Thompson, who presided over the last executions in the state, called the current system a “failed public policy.” Thompson said that he was concerned about his staff, who had the responsibility of carrying out executions, and about the risk that some innocent people have been executed in the U.S. Retired Supreme Court Justice Edwin Peterson also announced at the sold-out event that he would begin speaking out publicly against the state’s death penalty.
(T. Buckley, “Killing doesn’t Pay,” Willamette Live, May 2013). See Cost and Innocence. Read more New Voices.
The British manufacturer Hikma Pharmaceuticals recently announced new rules to restrict the supply of its products for unintended uses, such as carrying out executions in the United States. Earlier this year, Reprieve, a legal advocacy organization based in London, found that a U.S. subsidiary of Hikma sold 100 grams of phenobarbital to the Arkansas Department of Corrections. Arkansas decided to use the new, untested drug in their lethal injection process when they were unable to secure supplies of the drugs they normally use. A spokesman for Hikma Pharmaceuticals said the order had been made as part of the regular request for drugs for prison hospital services and did not raise any red flags because the drug had never been used in executions before. Arkansas has been contacted by the drug company and told that the subsidiary was closing the account. The state's current supply of phenobarbital is sufficient to carry out eight executions and will expire in October 2015. The state will need to seek alternative sources or different drugs when their current supply becomes unavailable. Other drug companies have put similar restrictions on the use of their drugs in executions.
There are no execution dates set in Arkansas, and legal challenges to the execution protocol continue.
(E. Pilkington, "British maker of death penalty drugs adds new restrictions for US buyers," The Guardian, May 15, 2013). See Executions and Lethal Injection.
